Back to All NewsBTL Vanquish FDA Cleared for Circumferential Reduction of Abdomen Area
Posted By American Med Spa Association, Tuesday, June 30, 2015
Share
BTL Industries received FDA clearance of its BTL Vanquish device for circumferential reduction of the 
abdomen area. BTL Vanquish uses a panel array that emits selective RF energy with the largest spot size in the industry to treat the entire core in one application. Providing a clinically proven and safe treatment option without touching the patient’s skin, the breakthrough technology of BTL Vanquish surpasses earlier treatment options that require uncomfortable suction or labor-intensive application. The system’s patented technology creates a high-frequency energy field that targets the thermal effects into the fat layer while protecting surrounding skin tissue.
Read more on AestheticsWire.
abdomen area. BTL Vanquish uses a panel array that emits selective RF energy with the largest spot size in the industry to treat the entire core in one application. Providing a clinically proven and safe treatment option without touching the patient’s skin, the breakthrough technology of BTL Vanquish surpasses earlier treatment options that require uncomfortable suction or labor-intensive application. The system’s patented technology creates a high-frequency energy field that targets the thermal effects into the fat layer while protecting surrounding skin tissue.Read more on AestheticsWire.
